Upcoming Medical Conferences in AshlandSearch Criteria : United States of America Ashland
Aug 01 - 03, 2019 | CME 12.75 | Ashland, Oregon
2019 Ashland Endocrine Conference is organized by Oregon Health & Science University (OHSU) and will be held from Aug 01 - 03, 2019 at Ashland Hills Hotel & Suites and Convention Center, Ashland, Oregon, United States of America. Target audience: Practicing endocrinologists and primary care providers. Accreditation: Oregon Health & Science University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. AMA Credit: OHSU School of Medicine designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Maintenance of Certification: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Participants’ personal information will be shared with the ACCME and the ABIM. AAFP Credit: This Live activity, Ashland Endocrine Conference, with a beginning date of 08/01/2019, has been reviewed and is acceptable for up to 12.50 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Course Description: This course is designed for practicing endocrinologists and primary care providers. The topics selected are common clinical problems that have resisted clear resolution. Leading experts have been gathered to discuss these issues in a casual atmosphere in order to promote open debate and clarification of the issues. All participants, including faculty and trainees, should benefit. At the conclusion of the program, participants should have enhanced knowledge of current clinical problems in metabolic and endocrine disorders. Objectives: At the conclusion of this course participants will: • Describe the clinical impact of diabetes distress and its effect on management and quality of life. • Discuss initiation and management of feminizing and masculinizing hormone therapy regimens for transgender and gender non-binary patients. • Identify appropriate candidates for menopausal hormone therapy and choose the optimal therapy for an individual based upon medical history. • Understand the dietary and pharmacologic treatments that lead to a reduction in recurrent kidney stone formation.